JP2021503015A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503015A5
JP2021503015A5 JP2020545238A JP2020545238A JP2021503015A5 JP 2021503015 A5 JP2021503015 A5 JP 2021503015A5 JP 2020545238 A JP2020545238 A JP 2020545238A JP 2020545238 A JP2020545238 A JP 2020545238A JP 2021503015 A5 JP2021503015 A5 JP 2021503015A5
Authority
JP
Japan
Prior art keywords
cells
pharmaceutical composition
composition according
modified
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503015A (ja
JP7568507B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061211 external-priority patent/WO2019099619A1/en
Publication of JP2021503015A publication Critical patent/JP2021503015A/ja
Publication of JP2021503015A5 publication Critical patent/JP2021503015A5/ja
Priority to JP2024172933A priority Critical patent/JP7787265B2/ja
Application granted granted Critical
Publication of JP7568507B2 publication Critical patent/JP7568507B2/ja
Priority to JP2025225428A priority patent/JP2026050368A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545238A 2017-11-15 2018-11-15 非骨髄破壊的な骨髄再構成のための方法および組成物 Active JP7568507B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024172933A JP7787265B2 (ja) 2017-11-15 2024-10-02 非骨髄破壊的な骨髄再構成のための方法および組成物
JP2025225428A JP2026050368A (ja) 2017-11-15 2025-12-03 非骨髄破壊的な骨髄再構成のための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762586813P 2017-11-15 2017-11-15
US62/586,813 2017-11-15
PCT/US2018/061211 WO2019099619A1 (en) 2017-11-15 2018-11-15 Methods and compositions for non-myeloablative bone marrow reconstitution

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024172933A Division JP7787265B2 (ja) 2017-11-15 2024-10-02 非骨髄破壊的な骨髄再構成のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2021503015A JP2021503015A (ja) 2021-02-04
JP2021503015A5 true JP2021503015A5 (https=) 2021-12-23
JP7568507B2 JP7568507B2 (ja) 2024-10-16

Family

ID=66539907

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020545238A Active JP7568507B2 (ja) 2017-11-15 2018-11-15 非骨髄破壊的な骨髄再構成のための方法および組成物
JP2024172933A Active JP7787265B2 (ja) 2017-11-15 2024-10-02 非骨髄破壊的な骨髄再構成のための方法および組成物
JP2025225428A Pending JP2026050368A (ja) 2017-11-15 2025-12-03 非骨髄破壊的な骨髄再構成のための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024172933A Active JP7787265B2 (ja) 2017-11-15 2024-10-02 非骨髄破壊的な骨髄再構成のための方法および組成物
JP2025225428A Pending JP2026050368A (ja) 2017-11-15 2025-12-03 非骨髄破壊的な骨髄再構成のための方法および組成物

Country Status (13)

Country Link
US (2) US12194062B2 (https=)
EP (2) EP3710013B1 (https=)
JP (3) JP7568507B2 (https=)
KR (1) KR20200089289A (https=)
CN (1) CN111417407A (https=)
AU (2) AU2018367546B2 (https=)
BR (1) BR112020009377A2 (https=)
CA (1) CA3082404A1 (https=)
ES (1) ES3039609T3 (https=)
IL (1) IL274632B2 (https=)
MX (2) MX2020004811A (https=)
SG (1) SG11202004145QA (https=)
WO (1) WO2019099619A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
CN115605084A (zh) * 2020-01-31 2023-01-13 S·居姆吕克曲（Ca） 用于提供化学保护作用的组合物和方法
US12390491B2 (en) * 2020-01-31 2025-08-19 Gtech Bio Llc Compositions and methods for providing chemoprotective effects

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109168A0 (en) * 1993-04-01 1994-06-24 Univ Columbia A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs
US7345025B2 (en) * 2001-07-10 2008-03-18 Johnson & Johnson Research Pty. Limited Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
US7737124B2 (en) 2001-09-13 2010-06-15 California Institute Of Technology Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
US20030099621A1 (en) * 2001-11-29 2003-05-29 Robert Chow Stem cell screening and transplantation therapy for HIV infection
CA2668608A1 (en) * 2006-11-08 2008-06-05 Aldagen, Inc. Methods for using aldhbr cells to supplement stem cell transplantation
WO2009094456A2 (en) * 2008-01-22 2009-07-30 Johns Hopkins University Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
EP3659435A1 (en) 2009-07-15 2020-06-03 Calimmune, Inc. Dual vector for inhibition of human immunodeficiency virus
US8837250B2 (en) 2010-07-20 2014-09-16 Taiwan Semiconductor Manufacturing Co., Ltd. Method and apparatus for word line decoder layout
MX370404B (es) * 2011-12-22 2019-12-11 Yeda Res & Dev Uso de una terapia de combinación para inducir un injerto estable y a largo plazo.
AU2013204327B2 (en) * 2012-04-20 2016-09-01 Aviagen Cell transfection method
JP2016522679A (ja) * 2013-04-04 2016-08-04 プレジデント アンド フェローズ オブ ハーバード カレッジ ＣＲＩＳＰＲ／Ｃａｓ系を用いたゲノム編集の治療的使用

Similar Documents

Publication Publication Date Title
JP2021503015A5 (https=)
RU2744603C2 (ru) Композиции, повышающие число копий вектора (чкв), и способы их применения
US11987628B2 (en) Methods and compositions for modulating CAR-T activity
EP3471743B1 (en) Strategies to assess and/or produce cell populations with predictive engraftment potential
JP2020505934A5 (https=)
IL274632B2 (en) Methods and compositions for non-myeloablative bone marrow reconstitution
WO2018064681A1 (en) Modified stem cell memory t cells, methods of making and methods of using same
EP4090743A1 (en) Modification of blood type antigens
US20240060090A1 (en) Genetically modified induced pluripotent stem cells and methods of use thereof
JP7633155B2 (ja) 人工トランス活性化因子による選択
Larochelle et al. In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene
JP2021522837A (ja) 造血幹細胞移植のための組成物及び方法
US20240181005A1 (en) Compositions, systems, and methods for generating gene-edited cells
JPWO2018088519A1 (ja) 遺伝子導入細胞の製造方法
CN112601812A (zh) 基因疗法
WO2019185920A1 (en) Tale-nucleases for allele-specific codon modification
WO2020158924A1 (ja) 母児間免疫寛容を誘導する方法
JP2020517289A5 (https=)
KR20250084928A (ko) 유전자 전달 효율이 향상된 트랜스포사제 돌연변이
CN121079404A (zh) 用于基因组编辑的组合物和方法
US20250177447A1 (en) Gprc5d-specific antibody constructs and compositions thereof
Quinn et al. 122. Genetic Modification of Target Cells by Direct Delivery of Active Protein
Qiu et al. Cell Insight
JP2020503335A (ja) Ｔ細胞を得る方法及び使用
WO2025046513A1 (en) Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof